High bone mass in mice lacking Cx37 because of defective osteoclast differentiation

Journal of Biological Chemistry

Volumn 289, Issue 12, 2014, Pages 8508-8520

  Pacheco Costa, Rafael ^a,b   Hassan, Iraj ^a   Reginato, Rejane D ^b   Davis, Hannah M ^a   Bruzzaniti, Angela ^c   Allen, Matthew R ^a   Plotkin, Lilian I ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; MAMMALS; OSTEOBLASTS; PROTEINS;

BONE FORMATION RATES; BONE MARROW CELLS; BONE MINERAL DENSITY; CALCITONIN RECEPTORS; CELL DIFFERENTIATION; MATRIX METALLOPROTEINASE-9; OSTEOCLAST DIFFERENTIATION; OSTEOCLAST PRECURSOR;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; CONNEXIN 37; DENDRITIC CELL SPECIFIC TRANSMEMBRANE PROTEIN; GELATINASE B; HERMES ANTIGEN; MEMBRANE PROTEIN; NFAT1 PROTEIN; NOTCH RECEPTOR; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW CELL; BONE MASS; CELL ACTIVITY; CELL COUNT; CELL FUSION; CELL MATURATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLASTOGENESIS; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

BONE; CX37; GAP JUNCTIONS; OSTEOBLASTS; OSTEOCLAST; OSTEOCYTE;

ANIMALS; BONE AND BONES; CELL DIFFERENTIATION; CONNEXINS; FEMALE; GENE DELETION; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOCLASTS;

EID: 84897013851     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.529735     Document Type: Article

References (54)

1. Plotkin, L. I., and Bellido, T. (2013) Beyond gap junctions: Connexin43 and bone cell signaling. Bone 52, 157-166
2. Nielsen, M. S., Nygaard Axelsen, L., Sorgen, P. L., Verma, V., Delmar, M., and Holstein-Rathlou, N. H. (2012) Gap junctions. Compr. Physiol. 2, 1981-2035
3. Hervé, J. C., Derangeon, M., Sarrouilhe, D., Giepmans, B. N., and Bourmeyster, N. (2012) Gap junctional channels are parts of multiprotein complexes. Biochim. Biophys. Acta 1818, 1844-1865
4. Segretain, D., and Falk, M. M. (2004) Regulation of connexin biosynthesis, assembly, gap junction formation, and removal. Biochim. Biophys. Acta 1662, 3-21 (Pubitemid 38366510)
5. White, T. W., Paul, D. L., Goodenough, D. A., and Bruzzone, R. (1995) Functional analysis of selective interactions among rodent connexins. Mol. Biol. Cell 6, 459-470
6. Paic, F., Igwe, J. C., Nori, R., Kronenberg, M. S., Franceschetti, T., Harrington, P., Kuo, L., Shin, D. G., Rowe, D. W., Harris, S. E., and Kalajzic, I. (2009) Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45, 682-692
7. Söhl, G., and Willecke, K. (2004) Gap junctions and the connexin protein family. Cardiovasc. Res. 62, 228-232 (Pubitemid 38496536)
8. Chanson, M., and Kwak, B. R. (2007) Connexin37: a potential modifier gene of inflammatory disease. J. Mol. Med. 85, 787-795 (Pubitemid 47077108)
9. Hanner, F., Sorensen, C. M., Holstein-Rathlou, N. H., and Peti-Peterdi, J. (2010) Connexins and the kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R1143-R1155
10. Figueroa, X. F., and Duling, B. R. (2009) Gap junctions in the control of vascular function. Antioxid. Redox Signal. 11, 251-266
11. Simon, A. M., and McWhorter, A. R. (2002) Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev. Biol. 251, 206-220 (Pubitemid 35373744)
12. Morel, S., Burnier, L., Roatti, A., Chassot, A., Roth, I., Sutter, E., Galan, K., Pfenniger, A., Chanson, M., and Kwak, B. R. (2010) Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis 31, 1922-1931
13. Yamada, Y., Ando, F., and Shimokata, H. (2007) Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med. 19, 791-801
14. Simon, A. M., Goodenough, D. A., Li, E., and Paul, D. L. (1997) Female infertility in mice lacking connexin 37. Nature 385, 525-529 (Pubitemid 27074669)
15. Kalajzic, I., Braut, A., Guo, D., Jiang, X., Kronenberg, M. S., Mina, M., Harris, M. A., Harris, S. E., and Rowe, D. W. (2004) Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35, 74-82 (Pubitemid 38789150)
16. Rhee, Y., Allen, M. R., Condon, K., Lezcano, V., Ronda, A. C., Galli, C., Olivos, N., Passeri, G., O'Brien, C. A., Bivi, N., Plotkin, L. I., and Bellido, T. (2011) PTH receptor signaling in osteocytes governs periosteal bone formation and intra-cortical remodeling. J. Bone Miner. Res. 26, 1035-1046
17. Bivi, N., Lezcano, V., Romanello, M., Bellido, T., and Plotkin, L. I. (2011) Connexin43 interacts with βarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone. J. Cell Biochem. 112, 2920-2930
18. Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., and Bellido, T. (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J. Clin. Invest. 104, 1363-1374
19. Thi, M. M., Urban-Maldonado, M., Spray, D. C., and Suadicani, S. O. (2010) Characterization of human telomerase reverse transcriptase (hTERT) immortalized osteoblast cell lines generated from wildtype and connexin43-null mouse calvaria. Am. J. Physiol. Cell Physiol. 299, C994-C1006
20. Bivi, N., Condon, K. W., Allen, M. R., Farlow, N., Passeri, G., Brun, L. R., Rhee, Y., Bellido, T., and Plotkin, L. I. (2012) Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J. Bone Miner. Res. 27, 374-389
21. Bivi, N., Bereszczak, J. Z., Romanello, M., Zeef, L. A., Delneri, D., Quadrifoglio, F., Moro, L., Brancia, F. L., and Tell, G. (2009) Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates. J. Proteome. Res. 8, 1131-1142
22. Niranjan, T., Bielesz, B., Gruenwald, A., Ponda, M. P., Kopp, J. B., Thomas, D. B., and Susztak, K. (2008) The Notch pathway in podocytes plays a role in the development of glomerular disease. Nat. Med. 14, 290-298 (Pubitemid 351347919)
23. Albers, J., Keller, J., Baranowsky, A., Beil, F. T., Catala-Lehnen, P., Schulze, J., Amling, M., and Schinke, T. (2013) Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. J. Cell Biol. 200, 537-549
24. Rodriguez, S., Chora, A., Goumnerov, B., Mumaw, C., Goebel, W. S., Fernandez, L., Baydoun, H., HogenEsch, H., Dombkowski, D. M., Karlewicz, C. A., Rice, S., Rahme, L. G., and Carlesso, N. (2009) Dysfunctional expansion of hematopoietic stem cells and block of myeloid differentiation in lethal sepsis. Blood 114, 4064-4076
25. Tu, X., Joeng, K. S., Nakayama, K. I., Nakayama, K., Rajagopal, J., Carroll, T. J., McMahon, A. P., and Long, F. (2007) Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev. Cell 12, 113-127 (Pubitemid 46002598)
26. Bivi, N., Pacheco-Costa, R., Brun, L. R., Murphy, T. R., Farlow, N. R., Robling, A. G., Bellido, T., and Plotkin, L. I. (2013) Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice. J. Orthop. Res. 31, 1075-1081
27. Dempster, D. W., Compston, J. E., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., Recker, R. R., and Parfitt, A. M. (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 28, 2-17
28. Plotkin, L. I., Bivi, N., and Bellido, T. (2011) A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice. Bone 49, 122-127
29. Allen, M. R., Reinwald, S., and Burr, D. B. (2008) Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment. Calcif. Tissue Int. 82, 354-360
30. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E. F., Mak, T. W., Kodama, T., and Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (Pubitemid 35460788)
31. Kania, J. R., Kehat-Stadler, T., and Kupfer, S. R. (1997) CD44 antibodies inhibit osteoclast formation. J. Bone Miner. Res. 12, 1155-1164 (Pubitemid 27334961)
32. Cackowski, F. C., Anderson, J. L., Patrene, K. D., Choksi, R. J., Shapiro, S. D., Windle, J. J., Blair, H. C., and Roodman, G. D. (2010) Osteoclasts are important for bone angiogenesis. Blood 115, 140-149
33. MacLauchlan, S., Skokos, E. A., Meznarich, N., Zhu, D. H., Raoof, S., Shipley, J. M., Senior, R. M., Bornstein, P., and Kyriakides, T. R. (2009) Macrophage fusion, giant cell formation, and the foreign body response require matrix metalloproteinase 9. J. Leukocyte. Biol. 85, 617-626
34. Ma, J., Liu, Y. L., Hu, Y. Y., Wei, Y. N., Zhao, X. C., Dong, G. Y., Qin, H. Y., Ding, Y., and Han, H. (2013) Disruption of the transcription factor RBP-J results in osteopenia attributable to attenuated osteoclast differentiation. Mol. Biol. Rep. 40, 2097-2105
35. Bai, S., Kopan, R., Zou, W., Hilton, M. J., Ong, C. T., Long, F., Ross, F. P., and Teitelbaum, S. L. (2008) NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells. J. Biol. Chem. 283, 6509-6518
36. Ilvesaro, J., and Tuukkanen, J. (2003) Gap-junctional regulation of osteoclast function. Crit. Rev. Eukaryot. Gene Expr. 13, 133-146 (Pubitemid 38009164)
37. Matemba, S. F., Lie, A., and Ransjö, M. (2006) Regulation of osteoclastogenesis by gap junction communication. J. Cell. Biochem. 99, 528-537 (Pubitemid 44435569)
38. Schilling, A. F., Filke, S., Lange, T., Gebauer, M., Brink, S., Baranowsky, A., Zustin, J., and Amling, M. (2008) Gap junctional communication in human osteoclasts in vitro and in vivo. J. Cell Mol. Med. 12, 2497-2504
39. Ilvesaro, J., Tavi, P., and Tuukkanen, J. (2001) Connexin-mimetic peptide Gap 27 decreases osteoclastic activity. BMC Musculoskelet. Disord. 2, 10
40. Kylmäoja, E., Kokkonen, H., Kauppinen, K., Hussar, P., Sato, T., Haugan, K., Larsen, B. D., and Tuukkanen, J. (2013) Osteoclastogenesis is influenced by modulation of gap junctional communication with antiarrhythmic peptides. Calcif. Tissue Int. 92, 270-281
41. Sternlieb, M., Paul, E., Donahue, H. J., and Zhang. Y. (2012) Ablation of connexin 43 in osteoclasts leads to decreased in vivo osteoclastogenesis. J. Bone Miner. Res. 27, S53
42. Lecanda, F., Warlow, P. M., Sheikh, S., Furlan, F., Steinberg, T. H., and Civitelli, R. (2000) Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J. Cell Biol. 151, 931-944
43. Burt, J. M., Nelson, T. K., Simon, A. M., and Fang, J. S. (2008) Connexin 37 profoundly slows cell cycle progression in rat insulinoma cells. Am. J. Physiol. Cell Physiol. 295, C1103-C1112 (Pubitemid 352790343)
44. Nelson, T. K., Sorgen, P. L., and Burt, J. M. (2013) Carboxy terminus and pore-forming domain properties specific to Cx37 are necessary for Cx37-mediated suppression of insulinoma cell proliferation. Am. J. Physiol. Cell Physiol. 305, C1246-C1256
45. Zhang, Y., Paul, E. M., Sathyendra, V., Davison, A., Sharkey, N.,Bronson, S., Srinivasan, S., Gross, T. S., and Donahue, H. J. (2011) Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS ONE 6, e23516
46. Watkins, M., Grimston, S. K., Norris, J. Y., Guillotin, B., Shaw, A., Beniash, E., and Civitelli, R. (2011) Osteoblast Connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol. Biol. Cell 22, 1240-1251
47. Ek-Vitorin, J. F., and Burt, J. M. (2013) Structural basis for the selective permeability of channels made of communicating junction proteins. Biochim. Biophys. Acta 1828, 51-68
48. Plotkin, L. I., Manolagas, S. C., and Bellido, T. (2002) Transduction of cell survival signals by connexin-43 hemichannels. J. Biol. Chem. 277, 8648-8657 (Pubitemid 34968331)
49. Li, T. Y., Colley, D., Barr, K. J., Yee, S. P., and Kidder, G. M. (2007) Rescue of oogenesis in Cx37-null mutant mice by oocyte-specific replacement with Cx43. J. Cell Sci. 120, 4117-4125
50. Bivi, N., Nelson, M. T., Faillace, M. E., Li, J., Miller, L. M., and Plotkin, L. I. (2012) Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone. Calcif. Tissue Int. 91, 215-224
51. Zappitelli, T., Chen, F., Moreno, L., Zirngibl, R. A., Grynpas, M., Henderson, J. E., and Aubin, J. E. (2013) The G60S Connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old age-related bone loss. J. Bone Miner. Res. 28, 2400-2413
52. Evans, W. H., and Leybaert, L. (2007) Mimetic peptides as blockers of connexin channel-facilitated intercellular communication. Cell Commun. Adhes. 14, 265-273
53. O'Carroll, S. J., Gorrie, C. A., Velamoor, S., Green, C. R., and Nicholson, L. F. (2013) Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury. Neurosci. Res. 75, 256-267
54. De Bock, M., Culot, M., Wang, N., Bol, M., Decrock, E., De Vuyst, E., da Costa, A., Dauwe, I., Vinken, M., Simon, A. M., Rogiers, V., De Ley, G., Evans, W. H., Bultynck, G., Dupont, G., Cecchelli, R., and Leybaert, L. (2011) Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 31, 1942-1957